Suppr超能文献

阿尔茨海默病是一种全身性疾病吗?

Is Alzheimer's disease a systemic disease?

作者信息

Morris Jill K, Honea Robyn A, Vidoni Eric D, Swerdlow Russell H, Burns Jeffrey M

机构信息

The University of Kansas Department of Neurology, University of Kansas, Alzheimer's Disease Center, USA.

出版信息

Biochim Biophys Acta. 2014 Sep;1842(9):1340-9. doi: 10.1016/j.bbadis.2014.04.012. Epub 2014 Apr 18.

Abstract

Although Alzheimer's disease (AD) is the most common neurodegenerative disease, the etiology of AD is not well understood. In some cases, genetic factors explain AD risk, but a high percentage of late-onset AD is unexplained. The fact that AD is associated with a number of physical and systemic manifestations suggests that AD is a multifactorial disease that affects both the CNS and periphery. Interestingly, a common feature of many systemic processes linked to AD is involvement in energy metabolism. The goals of this review are to 1) explore the evidence that peripheral processes contribute to AD risk, 2) explore ways that AD modulates whole-body changes, and 3) discuss the role of genetics, mitochondria, and vascular mechanisms as underlying factors that could mediate both central and peripheral manifestations of AD. Despite efforts to strictly define AD as a homogeneous CNS disease, there may be no single etiologic pathway leading to the syndrome of AD dementia. Rather, the neurodegenerative process may involve some degree of baseline genetic risk that is modified by external risk factors. Continued research into the diverse but related processes linked to AD risk is necessary for successful development of disease-modifying therapies.

摘要

尽管阿尔茨海默病(AD)是最常见的神经退行性疾病,但其病因尚未完全明确。在某些情况下,遗传因素可解释AD的发病风险,但相当一部分晚发型AD的病因仍不清楚。AD与多种身体和全身表现相关,这表明AD是一种多因素疾病,会影响中枢神经系统(CNS)和外周。有趣的是,许多与AD相关的全身过程的一个共同特征是参与能量代谢。本综述的目的是:1)探讨外周过程导致AD风险的证据;2)探讨AD调节全身变化的方式;3)讨论遗传、线粒体和血管机制作为潜在因素在介导AD中枢和外周表现方面的作用。尽管人们努力将AD严格定义为一种单一的中枢神经系统疾病,但可能不存在导致AD痴呆综合征的单一病因途径。相反,神经退行性过程可能涉及一定程度的基线遗传风险,该风险会受到外部风险因素的影响。持续研究与AD风险相关的各种但相关的过程对于成功开发疾病修饰疗法至关重要。

相似文献

1
Is Alzheimer's disease a systemic disease?阿尔茨海默病是一种全身性疾病吗?
Biochim Biophys Acta. 2014 Sep;1842(9):1340-9. doi: 10.1016/j.bbadis.2014.04.012. Epub 2014 Apr 18.

引用本文的文献

1
Amyloid-β and heart failure in Alzheimer's disease: the new vistas.阿尔茨海默病中的β-淀粉样蛋白与心力衰竭:新视野
Front Med (Lausanne). 2025 Feb 4;12:1494101. doi: 10.3389/fmed.2025.1494101. eCollection 2025.

本文引用的文献

1
Impaired glycemia increases disease progression in mild cognitive impairment.血糖受损会加速轻度认知障碍的疾病进展。
Neurobiol Aging. 2014 Mar;35(3):585-9. doi: 10.1016/j.neurobiolaging.2013.09.033. Epub 2013 Oct 23.
5
The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.阿尔茨海默病的线粒体级联假说:进展与展望
Biochim Biophys Acta. 2014 Aug;1842(8):1219-31. doi: 10.1016/j.bbadis.2013.09.010. Epub 2013 Sep 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验